These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27557349)

  • 21. The Mind Bending Quest for Cognitive Enhancers.
    Arce E; Ehlers MD
    Clin Pharmacol Ther; 2017 Feb; 101(2):179-181. PubMed ID: 27706806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine.
    Roberts CA; Jones A; Sumnall H; Gage SH; Montgomery C
    Eur Neuropsychopharmacol; 2020 Sep; 38():40-62. PubMed ID: 32709551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
    Brady KT; Gray KM; Tolliver BK
    Pharmacol Biochem Behav; 2011 Aug; 99(2):285-94. PubMed ID: 21557964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the effects of modafinil on cognition in schizophrenia.
    Morein-Zamir S; Turner DC; Sahakian BJ
    Schizophr Bull; 2007 Nov; 33(6):1298-306. PubMed ID: 17634412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive enhancers for anxiety disorders.
    Hofmann SG; Smits JA; Asnaani A; Gutner CA; Otto MW
    Pharmacol Biochem Behav; 2011 Aug; 99(2):275-84. PubMed ID: 21134394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 27. Cognitive enhancers--performance or problem?
    Sharp C
    Occup Med (Lond); 2016 Mar; 66(2):88-9. PubMed ID: 26892595
    [No Abstract]   [Full Text] [Related]  

  • 28. Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial.
    Goez HR; Scott O; Nevo N; Bennett-Back O; Zelnik N
    J Child Neurol; 2012 Dec; 27(12):1547-52. PubMed ID: 22447850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults: The Clinical and Ethical Debates.
    Koren G; Korn L
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):100-102. PubMed ID: 33666399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review.
    Battleday RM; Brem AK
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1865-81. PubMed ID: 26381811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs under investigation for attention-deficit hyperactivity disorder.
    Schweitzer JB; Holcomb HH
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1207-11. PubMed ID: 12211416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How smart are smart drugs?
    Rose S
    Lancet; 2008 Jul; 372(9634):198-9. PubMed ID: 18646294
    [No Abstract]   [Full Text] [Related]  

  • 33. Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure.
    d'Angelo LC; Savulich G; Sahakian BJ
    Br J Pharmacol; 2017 Oct; 174(19):3257-3267. PubMed ID: 28427114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expectations regarding cognitive enhancement create substantial challenges.
    Racine E; Forlini C
    J Med Ethics; 2009 Aug; 35(8):469-70. PubMed ID: 19644002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder.
    Wilens TE; Waxmonsky J; Scott M; Swezey A; Kwon A; Spencer TJ; Biederman J
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):947-55. PubMed ID: 16379515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethical aspects of the abuse of pharmaceutical enhancements by healthy people in the context of improving cognitive functions.
    Tomažič T; Čelofiga AK
    Philos Ethics Humanit Med; 2019 Apr; 14(1):7. PubMed ID: 31023334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gin and juice: modafinil tightens up the drinker's brain at rest.
    Minzenberg MJ
    Biol Psychiatry; 2013 Apr; 73(8):704-5. PubMed ID: 23540352
    [No Abstract]   [Full Text] [Related]  

  • 38. Cognition enhancers between treating and doping the mind.
    Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
    Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive enhancement, cheating, and accomplishment.
    Goodman R
    Kennedy Inst Ethics J; 2010 Jun; 20(2):145-60. PubMed ID: 20653250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial.
    Amiri S; Mohammadi MR; Mohammadi M; Nouroozinejad GH; Kahbazi M; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):145-9. PubMed ID: 17765380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.